missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human EDC4 (aa 427-534) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (94%), Rat (94%). This recombinant protein control fragment may be used for blocking experiments. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
In the process of mRNA degradation, seems to play a role in mRNA decapping. Component of a complex containing DCP2 and DCP1A which functions in decapping of ARE-containing mRNAs. Promotes complex formation between DCP1A and DCP2. Enhances the catalytic activity of DCP2 (in vitro).
Specifications
Specifications
| Accession Number | Q6P2E9 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 23644 |
| Name | Human EDC4 (aa 427-534) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | Autoantigen Ge-1; autoantigen RCD8; autoantigen RCD-8; BC022641; Edc4; enhancer of mRNA decapping 4; enhancer of mRNA-decapping protein 4; fe26b05; GE1; Ge-1; HEDL5; HEDLS; Human enhancer of decapping large subunit; LRRG00115; Nrn1l; RCD8; RCD-8; RGD1309136; si:ch211-237c7.1; si:dkey-16n13.6; wu:fe26b05 |
| Common Name | EDC4 |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction